Avilar Therapeutics
Avilar Therapeutics is a biotech company in Waltham, United States. It has raised $60.0M across 2 rounds, most recently a Seed in February 2023.
Extending degradation to the universe of extracellular proteins
- Headquarters
- Waltham, Massachusetts
- Employees
- 11–50
- Website
- avilar-tx.com
- Total Funding
- $60.0M
- Last Round
- SeedFeb 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
Avilar Therapeutics develops ATACs (ASGPR Targeting Chimeras), a class of degraders that harnesses a natural endogenous process for protein degradation. Its bespoke, integrated and modular drug discovery platform enables the design and assembly of degraders targeting a wide array of extracellular proteins.
Summary
It lists 11–50 employees. It has raised $60.0M in total across 2 rounds, most recently a Seed round in Feb 2023. Investors include RA Capital Management, Sanofi Ventures and Astellas Venture Management.
Funding History
Feb 2023
Sign up to see all 2 events
Funding: Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/avilar-therapeutics"><img src="https://indexed.vc/api/badge/company/avilar-therapeutics" alt="Avilar Therapeutics on Indexed.vc" width="260" height="76" /></a>